Development and validation of a pathological model predicting the efficacy of neoadjuvant therapy for breast cancer based on RCB scoring
Introduction Breast cancer has become the most prevalent malignant tumor among women globally, posing a serious threat to women’s life and health. Neoadjuvant therapy (NAT) has emerged as one of the standard treatment approaches for breast cancer patients. However, due to varying responses to NAT am...
Saved in:
| Main Authors: | Huan Li, Xianli Ju, Chuanfei Zeng, Zhengzhuo Chen, LinXin Yu, Ge Ke, Ziyin Huang, Youping Wang, Jingping Yuan, Mingkai Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-05-01
|
| Series: | Archives of Medical Science |
| Subjects: | |
| Online Access: | https://www.archivesofmedicalscience.com/Development-and-validation-of-a-pathological-model-predicting-the-efficacy-of-neoadjuvant,188006,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the use of Radiomics and Pathomics for predicting the efficacy of neoadjuvant therapy in tumors
by: Jiayi Wang, et al.
Published: (2025-08-01) -
Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis
by: Soo-Young Lee, et al.
Published: (2025-04-01) -
Tumor Morphology for Prediction of Poor Responses Early in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study
by: Wen Li, et al.
Published: (2024-11-01) -
The prognostic value of lymph node response to neoadjuvant therapy among breast cancer subtypes
by: Oana-Adriana RAJPUT-ANGHEL, et al.
Published: (2024-06-01) -
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
by: Roberto A. Leon-Ferre, et al.
Published: (2025-06-01)